NCT05023369View on ClinicalTrials.gov

This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time

PHASE4RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions
Femoral Neck Fractures
Interventions
DRUG

Dexamethasone is a steroid drug and will be administered as an injectable solution (4mg/ml)

Dexamethasone will be administered as an injectable solution (4mg/ml). Every ml of this solution contains 4 mg of dexamethasone sodium phosphate, corresponding to 3 mg of dexamethasone. Thus 3 ml of solution will be injected peri-articularly (arm-A)

Trial Locations (1)

6900

RECRUITING

Christian Candrian, Lugano

All Listed Sponsors
lead

Ente Ospedaliero Cantonale, Bellinzona

OTHER

NCT05023369 - This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time | Biotech Hunter | Biotech Hunter